Ruth Pearson, NP
Family · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ruth Pearson’s office at (650) 498-6000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 15 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 15 | None | 0% (0) | 0% | $346 |
| 2020 | 51 | 21 | None | None | $62,090 |
| 2019 | 162 | 46 | 26% (42) | 13% | $57,653 |
| 2018 | 106 | 30 | 35% (37) | None | $11,593 |
| 2017 | 135 | 36 | 21% (28) | 19% | $40,274 |
| 2016 | 162 | 43 | 18% (29) | 29% | $234,831 |
| 2015 | 94 | 25 | 16% (15) | 29% | $107,987 |
| 2014 | 43 | 15 | None | None | $3,295 |
| 2013 | 40 | 16 | None | None | $942 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Imatinib Mesylate | 13 | $2,654 | $204 |
2019: 2 drugs
| Imatinib Mesylate | 14 | $8,501 | $607 |
| Oxycodone | 16 | $351 | $22 |
2018: 1 drug
| Oxycodone | 16 | $318 | $20 |
2017: 2 drugs
| Votrient | 12 | $33,104 | $2,759 |
| Lorazepam | 15 | $136 | $9 |
2016: 2 drugs
| Gleevec | 11 | $103,897 | $9,445 |
| Votrient | 12 | $74,254 | $6,188 |
2015: 1 drug
| Gleevec | 12 | $96,427 | $8,036 |
Money from drug and device companies
$365 in 2022
| 2022 | 3 | 6 | None | $365 |
| 2021 | 1 | 1 | None | $124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Iti | Caplyta | $226 | 3 payments
|
| Alkermes | Lybalvi | $114 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $25 | 1 payment
|
See all 6 published payments
| Iti | Meals · 2022-05-18 | Caplyta | $94 |
| Neurocrine Biosciences | Meals · 2022-02-12 | Ingrezza | $25 |
| Iti | Meals · 2022-02-09 | Caplyta | $116 |
| Alkermes | Meals · 2022-01-19 | Lybalvi | $94 |
| Alkermes | Meals · 2022-01-14 | Aristada | $20 |
| Iti | Meals · 2022-01-12 | Caplyta | $16 |
See earlier years (2021)
2021: $124
| Alkermes | Lybalvi | $124 | 1 payment
|
Professional record
- NPI
- 1346571205
- Licence
- CA NP19545
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 4142 Adams Ave Ste 103-338, San Diego, CA, 92116
- NPI first listed
- 2010-01-15
- NPI last updated
- 2022-01-12
- NPI record certified
- 2022-01-12
This is when the NPI record was last certified, not a medical board exam.